Epilepsy Surgery Market Forecast till 2027

  • Single User - $4450
  • Multi User - $6250
  • Enterprise User - $6250
  • Buy Report

Epilepsy Surgery Market: Information by Procedure Type (Resective Surgery, Laser Interstitial Thermal Therapy (LITT),), by End User (Hospitals & Clinics, Specialty Centers) and by Region (Americas, Europe, Asia-Pacific, and Middle East & Africa)—Forecast till 2027 Market Overview The global epilepsy surgery market is expected to register a notable CAGR of CAGR 5.72% during the review period to surpass USD 1,402.32 million by the end of 2027. The epilepsy surgery is accomplished to minimize the probability of seizures. Developing business sectors are expected to offer potential development openings for worldwide market players working in the market because of mechanical progressions, the developing old populace inclined to seizure problems, and government drives in endeavor research initiatives on epilepsy medical procedures. The epilepsy medical procedure market is projected to display critical development over the figure time frame, credited to variables like quick mechanical progressions in the gadgets, better clinical offices, and an expanding patient pool needing careful therapy. The global epilepsy surgery market is expected to witness a healthy market expansion a significant growth rate owing to the growing incidences of neurological disorders leading to exclusive R&D on epilepsy treatment devices and growing prevalence of brain injuries because of growing road accidents. Moreover, progresses in a robot-helped medical procedure and an increment in the geriatric populace are probably going to drive market development. Be that as it may, changes related to epilepsy surgeries may restrain the market development. Market Segmentation The epilepsy surgery market has been categorized into procedure type and ends user. By procedure type the global market has been categorized into Resective surgery, Laser Interstitial Thermal Therapy (LITT), and others. In terms of end users, the market has been classified into hospitals & clinics, specialty centers, and others. Regional Analysis Geographically, the epilepsy medical procedure market, has been partitioned into the Americas, Europe, Asia-Pacific, and the Middle East and Africa. The Americas is likely to command the epilepsy medical procedure market owing to different elements, like the accessibility of grounded medical services offices, the high pervasiveness of neurological issues, and the expanding rate of epilepsy. North America is separated into the US and Canada. It is assessed that approximately 150,000 Americans are determined to have Central Nervous System (CNS) jumble that causes seizures and is the fourth most normal neurological infection. With expanding interest in research and improvement, the creation of effective epilepsy meds, and a high pervasiveness of epilepsy, Europe has additionally developed as a noticeable market for epilepsy medical procedures. The Asia-Pacific area offers rewarding freedoms for players in the epilepsy medical procedure market is driven by the presence of an enormous geriatric populace, legislative drives to further develop the medical care area, an increment in research and advancement exercises, and an increment in epilepsy occurrence in the region. The Middle East &Africa epilepsy medical procedure market is fragmented into significant areas, to be specific the Middle East, Africa, and Latin America. Major Players The prominent market players operating in the global Epilepsy surgeries market include Stryker (US), Intuitive Surgical (US), Medtronic Plc (Mazor Robotics) (Ireland), Cephalon, Inc. (US), CMR Surgical (UK), Natus Medical Incorporated (US), Zimmer Biomet Holdings Inc. (US), Auris Health, Inc. (Hansen Medical, Inc.) (US), Livanova Plc (UK), and Monteris Medical (US). COVID 19 Impacts We are continuously tracking the impact of the COVID-19 pandemic on various industries and verticals within all domains. Our research reports include the same and help you understand the drop and rise, owing to the impact of COVID-19 on the industries. Also, we help you to identify the gap between the demand and supply of your interested market. Moreover, the report helps you with the analysis, amended government regulations, and many other useful insights.

TABLE OF CONTENTS 1 EXECUTIVE SUMMARY 2 MARKET INTRODUCTION 2.1 SCOPE OF THE STUDY 2.2 RESEARCH OBJECTIVE 2.3 MARKET STRUCTURE 2.4 ASSUMPTIONS & LIMITATIONS 3 RESEARCH METHODOLOGY 3.1 DATA MINING 3.2 SECONDARY RESEARCH 3.3 PRIMARY RESEARCH 3.4 BREAKDOWN OF PRIMARY RESPONDENTS 3.5 FORECASTING TECHNIQUES 3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION 3.6.1 BOTTOM-UP APPROACH 3.6.2 TOP-DOWN APPROACH 3.7 DATA TRIANGULATION 3.8 VALIDATION 4 MARKET DYNAMICS 4.1 OVERVIEW 4.2 DRIVERS 4.2.1 INCREASING PREVALENCE OF EPILEPSY AND DEMAND FOR SURGICAL PROCEDURES 4.2.2 RISING NUMBER OF CASES OF BRAIN INJURIES DUE TO ROAD ACCIDENTS 4.2.3 ADVANCEMENT AND ADOPTION OF ROBOT-ASSISTED SURGERY 4.3 RESTRAINT 4.3.1 STRINGENT GOVERNMENT REGULATIONS AND COMPLICATIONS ASSOCIATED WITH SURGERY 4.4 OPPORTUNITY 4.4.1 COLLABORATION WITH RESEARCH INSTITUTES FOR MARKET ENTRANTS TO ACCESS GLOBAL MARKETS 5 MARKET FACTOR ANALYSIS 5.1 VALUE CHAIN ANALYSIS 5.1.1 R&D 5.1.2 MANUFACTURING 5.1.3 DISTRIBUTION 5.1.4 MARKETING & SALES 5.2 PORTER'S FIVE FORCES MODEL 5.2.1 BARGAINING POWER OF BUYERS 5.2.2 BARGAINING POWER OF SUPPLIERS 5.2.3 THREAT OF NEW ENTRANTS 5.2.4 THREAT OF SUBSTITUTES 5.2.5 INTENSITY OF RIVALRY 5.3 IMPACT OF COVID-19 5.3.1 IMPACT ON SUPPLY CHAIN 5.3.2 IMPACT ON DEMAND 5.3.3 AVAILABILITY AND ACCESS TO HEALTHCARE FACILITIES 5.3.4 IMPACT ON REVENUE AND STRATEGIC DECISIONS BY COMPANIES 6 GLOBAL EPILEPSY SURGERY MARKET BY PROCEDURE TYPE 6.1 OVERVIEW 6.2 RESECTIVE SURGERY 6.3 LASER INTERSTITIAL THERMAL THERAPY (LITT) 6.4 OTHERS 7 GLOBAL EPILEPSY SURGERY MARKET BY END USER 7.1 OVERVIEW 7.2 HOSPITALS & CLINICS 7.3 SPECIALTY CENTERS 7.4 OTHERS 8 GLOBAL EPILEPSY SURGERY MARKET, BY REGION 8.1 OVERVIEW 8.2 AMERICAS 8.2.1 NORTH AMERICA 8.2.1.1 US 8.2.1.2 CANADA 8.2.2 LATIN AMERICA 8.3 EUROPE 8.3.1 WESTERN EUROPE 8.3.1.1 GERMANY 8.3.1.2 UK 8.3.1.3 FRANCE 8.3.1.4 ITALY 8.3.1.5 SPAIN 8.3.1.6 REST OF WESTERN EUROPE 8.3.2 EASTERN EUROPE 8.4 ASIA PACIFIC 8.4.1 CHINA 8.4.2 JAPAN 8.4.3 INDIA 8.4.4 SOUTH KOREA 8.4.5 AUSTRALIA 8.4.6 REST OF ASIA PACIFIC 8.5 MIDDLE EAST & AFRICA 8.5.1 MIDDLE EAST 8.5.2 AFRICA 9 COMPETITIVE LANDSCAPE 9.1 OVERVIEW 9.2 COMPETITIVE BENCHMARKING 9.3 MAJOR GROWTH STRATEGY IN THE GLOBAL EPILEPSY SURGERY MARKET 9.4 THE LEADING PLAYER IN TERMS OF THE NUMBER OF DEVELOPMENTS IN THE GLOBAL EPILEPSY SURGERY MARKET 9.5 KEY DEVELOPMENT ANALYSIS 9.6 KEY DEVELOPMENTS & GROWTH STRATEGIES 9.6.1 PRODUCT LAUNCH/PRODUCT APPROVAL 9.6.2 MERGER/ACQUISITION 9.7 FINANCIAL MATRIX 9.7.1 SALES (USD MILLION), 2020 9.7.2 RESEARCH & DEVELOPMENT EXPENDITURE (USD MILLION), 2020 10 COMPANY PROFILES 10.1 STRYKER 10.1.1 COMPANY OVERVIEW 10.1.2 FINANCIAL OVERVIEW 10.1.3 PRODUCTS/SERVICES OFFERED 10.1.4 KEY DEVELOPMENTS 10.1.5 SWOT ANALYSIS 10.1.6 KEY STRATEGIES 10.2 ZIMMER BIOMET HOLDINGS INC. 10.2.1 COMPANY OVERVIEWS 10.2.2 FINANCIAL OVERVIEW 10.2.3 PRODUCTS/SERVICES OFFERED 10.2.4 KEY DEVELOPMENTS 10.2.5 SWOT ANALYSIS 10.2.6 KEY STRATEGIES 10.3 AURIS HEALTH, INC. (HANSEN MEDICAL, INC.) 10.3.1 COMPANY OVERVIEW 10.3.2 FINANCIAL OVERVIEW 10.3.3 PRODUCTS/SERVICES OFFERED 10.3.4 KEY DEVELOPMENTS 10.3.5 SWOT ANALYSIS 10.3.6 KEY STRATEGIES 10.4 INTUITIVE SURGICAL 10.4.1 COMPANY OVERVIEW 10.4.2 FINANCIAL OVERVIEW 10.4.3 PRODUCTS/SERVICES OFFERED 10.4.4 KEY DEVELOPMENTS 10.4.5 SWOT ANALYSIS 10.4.6 KEY STRATEGIES 10.5 MEDTRONIC PLC (MAZOR ROBOTICS) 10.5.1 COMPANY OVERVIEW 10.5.2 FINANCIAL OVERVIEW 10.5.3 PRODUCTS/SERVICES OFFERED 10.5.4 KEY DEVELOPMENTS 10.5.5 SWOT ANALYSIS 10.5.6 KEY STRATEGIES 10.6.4 KEY DEVELOPMENTS 10.7 CMR SURGICAL 10.7.1 COMPANY OVERVIEW 10.7.2 FINANCIAL OVERVIEW 10.7.3 PRODUCTS/SERVICES OFFERED 10.7.4 KEY DEVELOPMENTS 10.7.5 SWOT ANALYSIS 10.7.6 KEY STRATEGIES 10.8 NATUS MEDICAL INCORPORATED 10.8.1 COMPANY OVERVIEW 10.8.2 FINANCIAL OVERVIEW 10.8.3 PRODUCTS OFFERED 10.8.4 KEY DEVELOPMENTS 10.8.5 SWOT ANALYSIS 10.8.6 KEY STRATEGIES 10.9 LIVANOVA PLC 10.9.1 COMPANY OVERVIEW 10.9.2 FINANCIAL OVERVIEW 10.9.3 PRODUCTS OFFERED 10.9.4 KEY DEVELOPMENTS 10.9.5 SWOT ANALYSIS 10.9.6 KEY STRATEGIES 10.10 MONTERIS MEDICAL 10.10.1 COMPANY OVERVIEW 10.10.2 FINANCIAL OVERVIEW 10.10.3 PRODUCTS/SERVICES OFFERED 10.10.4 KEY DEVELOPMENTS 10.10.5 SWOT ANALYSIS 10.10.6 KEY STRATEGIES 11 APPENDIX 11.1 REFERENCES 11.2 RELATED REPORTS  

LIST OF TABLES TABLE 1 LIST OF ASSUMPTIONS & LIMITATIONS TABLE 2 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS TABLE 3 GLOBAL: EPILEPSY SURGERY MARKET, BY PROCEDURE TYPE, 2018-2027 (USD MILLION) TABLE 4 GLOBAL: EPILEPSY SURGERY MARKET, BY RESECTIVE SURGERY, 2018–2027 (USD MILLION) TABLE 5 GLOBAL: EPILEPSY SURGERY MARKET, BY LASER INTERSTITIAL THERMAL THERAPY (LITT), 2018–2027 (USD MILLION) TABLE 6 GLOBAL: EPILEPSY SURGERY MARKET, BY OTHERS, 2018–2027 (USD MILLION) TABLE 7 GLOBAL: EPILEPSY SURGERY MARKET, BY END USER, 2018-2027 (USD MILLION) TABLE 8 GLOBAL: EPILEPSY SURGERY MARKET, BY HOSPITALS & CLINICS, 2018–2027 (USD MILLION) TABLE 9 GLOBAL: EPILEPSY SURGERY MARKET, BY SPECIALTY CENTERS, 2018–2027 (USD MILLION) TABLE 10 GLOBAL: EPILEPSY SURGERY MARKET, BY OTHERS, 2018–2027 (USD MILLION) TABLE 11 GLOBAL: EPILEPSY SURGERY MARKET, BY REGION, 2018–2027 (USD MILLION) TABLE 12 AMERICAS EPILEPSY SURGERY MARKET, BY REGION, 2018-2027 (USD MILLION) TABLE 13 AMERICAS EPILEPSY SURGERY MARKET, BY PROCEDURE TYPE, 2018-2027 (USD MILLION) TABLE 14 AMERICAS EPILEPSY SURGERY MARKET, BY END USER, 2018-2027 (USD MILLION) TABLE 15 NORTH AMERICA EPILEPSY SURGERY MARKET, BY COUNTRY, 2018-2027 (USD MILLION) TABLE 16 NORTH AMERICA EPILEPSY SURGERY MARKET, BY PROCEDURE TYPE, 2018-2027 (USD MILLION) TABLE 17 NORTH AMERICA EPILEPSY SURGERY MARKET, BY END USER, 2018-2027 (USD MILLION) TABLE 18 US EPILEPSY SURGERY MARKET, BY PROCEDURE TYPE, 2018-2027 (USD MILLION) TABLE 19 US EPILEPSY SURGERY MARKET, BY END USER, 2018-2027 (USD MILLION) TABLE 20 CANADA EPILEPSY SURGERY MARKET, BY PROCEDURE TYPE, 2018-2027 (USD MILLION) TABLE 21 CANADA EPILEPSY SURGERY MARKET, BY END USER, 2018-2027 (USD MILLION) TABLE 22 LATIN AMERICA EPILEPSY SURGERY MARKET, BY PROCEDURE TYPE, 2018-2027 (USD MILLION) TABLE 23 LATIN AMERICA EPILEPSY SURGERY MARKET, BY END USER, 2018-2027 (USD MILLION) TABLE 24 EUROPE EPILEPSY SURGERY MARKET, BY REGION, 2018-2027 (USD MILLION) TABLE 25 EUROPE EPILEPSY SURGERY MARKET, BY PROCEDURE TYPE, 2018-2027 (USD MILLION) TABLE 26 EUROPE EPILEPSY SURGERY MARKET, BY END USER, 2018-2027 (USD MILLION) TABLE 27 WESTERN EUROPE EPILEPSY SURGERY MARKET, BY COUNTRY, 2018-2027 (USD MILLION) TABLE 28 WESTERN EUROPE EPILEPSY SURGERY MARKET, BY PROCEDURE TYPE, 2018-2027 (USD MILLION) TABLE 29 AMERICAS EPILEPSY SURGERY MARKET, BY END USER, 2018-2027 (USD MILLION) TABLE 30 GERMANY EPILEPSY SURGERY MARKET, BY PROCEDURE TYPE, 2018-2027 (USD MILLION) TABLE 31 GERMANY EPILEPSY SURGERY MARKET, BY END USER, 2018-2027 (USD MILLION) TABLE 32 UK EPILEPSY SURGERY MARKET, BY PROCEDURE TYPE, 2018-2027 (USD MILLION) TABLE 33 UK EPILEPSY SURGERY MARKET, BY END USER, 2018-2027 (USD MILLION) TABLE 34 FRANCE EPILEPSY SURGERY MARKET, BY PROCEDURE TYPE, 2018-2027 (USD MILLION) TABLE 35 FRANCE EPILEPSY SURGERY MARKET, BY END USER, 2018-2027 (USD MILLION) TABLE 36 ITALY EPILEPSY SURGERY MARKET, BY PROCEDURE TYPE, 2018-2027 (USD MILLION) TABLE 37 ITALY EPILEPSY SURGERY MARKET, BY END USER, 2018-2027 (USD MILLION) TABLE 38 SPAIN EPILEPSY SURGERY MARKET, BY PROCEDURE TYPE, 2018-2027 (USD MILLION) TABLE 39 SPAIN EPILEPSY SURGERY MARKET, BY END USER, 2018-2027 (USD MILLION) TABLE 40 REST OF WESTERN EUROPE EPILEPSY SURGERY MARKET, BY PROCEDURE TYPE, 2018-2027 (USD MILLION) TABLE 41 REST OF WESTERN EUROPE EPILEPSY SURGERY MARKET, BY END USER, 2018-2027 (USD MILLION) TABLE 42 EASTERN EUROPE EPILEPSY SURGERY MARKET, BY PROCEDURE TYPE, 2018-2027 (USD MILLION) TABLE 43 EASTERN EUROPE EPILEPSY SURGERY MARKET, BY END USER, 2018-2027 (USD MILLION) TABLE 44 ASIA PACIFIC: EPILEPSY SURGERY MARKET, BY COUNTRY, 2018–2027 (USD MILLION) TABLE 45 ASIA-PACIFIC: EPILEPSY SURGERY MARKET, BY PROCEDURE TYPE, 2018–2027 (USD MILLION) TABLE 46 ASIA-PACIFIC: EPILEPSY SURGERY MARKET, BY END USER, 2018–2027 (USD MILLION) TABLE 47 CHINA: EPILEPSY SURGERY MARKET, BY PROCEDURE TYPE, 2018–2027 (USD MILLION) TABLE 48 CHINA: EPILEPSY SURGERY MARKET, BY END USER, 2018–2027 (USD MILLION) TABLE 49 JAPAN: EPILEPSY SURGERY MARKET, BY PROCEDURE TYPE, 2018–2027 (USD MILLION) TABLE 50 JAPAN: EPILEPSY SURGERY MARKET, BY END USER, 2018–2027 (USD MILLION) TABLE 51 INDIA: EPILEPSY SURGERY MARKET, BY PROCEDURE TYPE, 2018–2027 (USD MILLION) TABLE 52 INDIA: EPILEPSY SURGERY MARKET, BY END USER, 2018–2027 (USD MILLION) TABLE 53 SOUTH KOREA: EPILEPSY SURGERY MARKET, BY PROCEDURE TYPE, 2018–2027 (USD MILLION) TABLE 54 SOUTH KOREA: EPILEPSY SURGERY MARKET, BY END USER, 2018–2027 (USD MILLION) TABLE 55 AUSTRALIA: EPILEPSY SURGERY MARKET, BY PROCEDURE TYPE, 2018–2027 (USD MILLION) TABLE 56 AUSTRALIA: EPILEPSY SURGERY MARKET, BY END USER, 2018–2027 (USD MILLION) TABLE 57 REST OF ASIA PACIFIC: EPILEPSY SURGERY MARKET, BY PROCEDURE TYPE, 2018–2027 (USD MILLION) TABLE 58 REST OF ASIA PACIFIC: EPILEPSY SURGERY MARKET, BY END USER, 2018–2027 (USD MILLION) TABLE 59 MIDDLE EAST & AFRICA: EPILEPSY SURGERY MARKET, BY COUNTRY, 2018–2027 (USD MILLION) TABLE 60 MIDDLE EAST & AFRICA: EPILEPSY SURGERY MARKET, BY PROCEDURE TYPE, 2018–2027 (USD MILLION) TABLE 61 MIDDLE EAST & AFRICA: EPILEPSY SURGERY MARKET, BY END USER, 2018–2027 (USD MILLION) TABLE 62 MIDDLE EAST: EPILEPSY SURGERY MARKET, BY PROCEDURE TYPE, 2018–2027 (USD MILLION) TABLE 63 MIDDLE EAST: EPILEPSY SURGERY MARKET, BY END USER, 2018–2027 (USD MILLION) TABLE 64 AFRICA: EPILEPSY SURGERY MARKET, BY PROCEDURE TYPE, 2018–2027 (USD MILLION) TABLE 65 AFRICA: EPILEPSY SURGERY MARKET, BY END USER, 2018–2027 (USD MILLION) TABLE 66 MAJOR PLAYERS IN THE GLOBAL EPILEPSY SURGERY MARKET TABLE 67 MOST ACTIVE PLAYER IN THE GLOBAL EPILEPSY SURGERY MARKET TABLE 68 PRODUCT LAUNCH/PRODUCT APPROVAL TABLE 69 MERGER/ACQUISITION TABLE 70 STRYKER: PRODUCTS/SERVICES OFFERED TABLE 71 ZIMMER BIOMET HOLDINGS INC.: PRODUCTS/SERVICES OFFERED TABLE 72 ZIMMER BIOMET HOLDINGS INC: KEY DEVELOPMENTS TABLE 73 AURIS HEALTH, INC. (HANSEN MEDICAL, INC.): PRODUCTS/SERVICES OFFERED TABLE 74 AURIS HEALTH, INC. (HANSEN MEDICAL, INC.): KEY DEVELOPMENTS TABLE 75 INTUITIVE SURGICAL: PRODUCTS/SERVICES OFFERED TABLE 76 INTUITIVE SURGICAL: KEY DEVELOPMENTS TABLE 77 MEDTRONIC PLC: PRODUCTS/SERVICES OFFERED TABLE 78 MEDTRONIC PLC: KEY DEVELOPMENTS TABLE 79 CEPHALON, INC.: PRODUCTS/SERVICES OFFERED TABLE 80 CMR SURGICAL: PRODUCTS/SERVICES OFFERED TABLE 81 CMR SURGICAL: KEY DEVELOPMENTS TABLE 82 NATUS MEDICAL INCORPORATED: PRODUCTS OFFERED TABLE 83 LIVANOVA PLC: PRODUCTS OFFERED TABLE 84 MONTERIS MEDICAL: PRODUCTS/SERVICES OFFERED TABLE 85 MONTERIS MEDICAL: KEY DEVELOPMENTS

Related Reports

Human Coagulation Factor VIII Market by Player, Region, Type, Application and Sales Channel

The global Human Coagulation Factor VIII market was valued at $XX million in 2020, and analysts predict the global market size will reach $XX million by the end of 2030, growing at a CAGR of XX% between 2021 and 2030. Since the COVID-19 virus outbreak in Dece ... read more

Category: Pharmaceuticals and Healthcare
Published: Mar 2022
Pages: 116
Single user Price: $2500
Acetylcysteine Market by Player, Region, Type, Application and Sales Channel

The global Acetylcysteine market was valued at $XX million in 2020, and analysts predict the global market size will reach $XX million by the end of 2030, growing at a CAGR of XX% between 2021 and 2030. Since the COVID-19 virus outbreak in December 2019, the ... read more

Category: Pharmaceuticals and Healthcare
Published: Mar 2022
Pages: 108
Single user Price: $2500
Monoclonal Antibody Diagnostic Reagents Market by Player, Region, Type, Application and Sales Channel

The global Monoclonal Antibody Diagnostic Reagents market was valued at $XX million in 2020, and analysts predict the global market size will reach $XX million by the end of 2030, growing at a CAGR of XX% between 2021 and 2030. Since the COVID-19 virus outbre ... read more

Category: Pharmaceuticals and Healthcare
Published: Mar 2022
Pages: 107
Single user Price: $2500
Liver Fibrosis Drug Market by Player, Region, Type, Application and Sales Channel

The global Liver Fibrosis Drug market was valued at $XX million in 2020, and analysts predict the global market size will reach $XX million by the end of 2030, growing at a CAGR of XX% between 2021 and 2030. Since the COVID-19 virus outbreak in December 2019, ... read more

Category: Pharmaceuticals and Healthcare
Published: Mar 2022
Pages: 105
Single user Price: $2500
Atorvastatin Calcium Market by Player, Region, Type, Application and Sales Channel

The global Atorvastatin Calcium market was valued at $XX million in 2020, and analysts predict the global market size will reach $XX million by the end of 2030, growing at a CAGR of XX% between 2021 and 2030. Since the COVID-19 virus outbreak in December 2019 ... read more

Category: Pharmaceuticals and Healthcare
Published: Mar 2022
Pages: 115
Single user Price: $2500